chrX-133536251-C-G
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_004484.4(GPC3):āc.1616G>Cā(p.Ser539Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000191 in 1,203,640 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004484.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPC3 | NM_004484.4 | c.1616G>C | p.Ser539Thr | missense_variant | 8/8 | ENST00000370818.8 | NP_004475.1 | |
GPC3 | NM_001164617.2 | c.1685G>C | p.Ser562Thr | missense_variant | 9/9 | NP_001158089.1 | ||
GPC3 | NM_001164618.2 | c.1568G>C | p.Ser523Thr | missense_variant | 8/8 | NP_001158090.1 | ||
GPC3 | NM_001164619.2 | c.1454G>C | p.Ser485Thr | missense_variant | 7/7 | NP_001158091.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000363 AC: 4AN: 110092Hom.: 0 Cov.: 21 AF XY: 0.0000309 AC XY: 1AN XY: 32316
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 182800Hom.: 0 AF XY: 0.0000296 AC XY: 2AN XY: 67458
GnomAD4 exome AF: 0.0000174 AC: 19AN: 1093548Hom.: 0 Cov.: 30 AF XY: 0.0000167 AC XY: 6AN XY: 359028
GnomAD4 genome AF: 0.0000363 AC: 4AN: 110092Hom.: 0 Cov.: 21 AF XY: 0.0000309 AC XY: 1AN XY: 32316
ClinVar
Submissions by phenotype
Simpson-Golabi-Behmel syndrome type 1;CN033288:Wilms tumor 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 15, 2024 | - - |
Wilms tumor 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 31, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at